Data / Form D filings / Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc.: Form D filings
Bluejay Therapeutics, Inc., a technology company in San Mateo, CA, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on May 10, 2024, reports $182 million sold of a $182 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 CONCAR DRIVE, SUITE 3-101, San Mateo, CA, 94402
- Phone
- (650) 218-5487
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1868267
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 10, 2024 | New notice | $181,999,946 | $181,999,946 | 19 | May 1, 2024 | sec.gov | |
| Aug 16, 2022 | New notice | $41,150,200 | $20,499,976 | $20,650,224 | 9 | Aug 9, 2022 | sec.gov |
| Jun 21, 2021 | New notice | $24,239,991 | $19,239,990 | $5,000,001 | 6 | Jun 10, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dan Estes | Director | |
| Pascal Krotee | Director | |
| Jianqing Li | Director | |
| Keting Chu | Executive Officer, Director | |
| Alon Lazarus | Director | |
| Dajun Yang | Director |
Other technology companies in California that filed recently
- OutLens, Inc. $32,000 · Nov 2, 2026
- ECFX, Inc. offering · Nov 2, 2026
- Redwagon Systems Inc. $1.2 million · Oct 30, 2026
- General Compute Inc. $132.2 million · Oct 30, 2026
- Promptiva Health Inc. offering · Oct 30, 2026
- thenevercompany.ai Inc. $200,000 · Oct 29, 2026
Every Form D from the week of May 6, 2024 · All recent filings in California · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Bluejay Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.